Modified compound 511 reverses nicotine addiction by normalizing the PKA-CREB-GluN2B-CaMKII signaling pathway in the ventral tegmental area
Phytomedicine · 2026-10 · 160 · 158646
DOI: 10.1016/j.phymed.2026.158646 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026-10. Verfasst von Jiasi Deng und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Hauptthemen laut MEDLINE: Ventral Tegmental Area, Tobacco Use Disorder, Signal Transduction. Die Arbeit nennt 63 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
BACKGROUND: Nicotine addiction is a chronic and relapsing disorder, but current therapies have limited effect with severe side effects. Modified Compound 511 (M511), optimized from the anti-addiction formula Compound 511, was innovatively employed in this study to evaluate its therapeutic intervention effects in nicotine addiction. PURPOSE: This study aimed to explore the efficacy of M511 in nicotine addiction intervention and elucidate the underlying mechanisms. METHODS: The therapeutic effect of M511 on nicotine addiction was evaluated using the conditional place preference (CPP) paradigm, with Varenicline as the positive control. Hematoxylin and eosin (HE) staining was performed for histopathological examination of visceral organs. c-Fos immunofluorescence was utilized to screen responsive brain regions. Network pharmacology and RNA sequencing (RNA-seq) of ventral tegmental area (VTA) tissue were integrated to predict key signaling pathways and targets, which were subsequently validated by Western blot and RT-qPCR. The PKA inhibitor H-89 was employed for target validation via CPP, Western blot, immunofluorescence, Nissl staining, and Golgi staining. LC-MS/MS was employed for chemical characterization of M511. RESULTS: M511 (6 g/kg, medium dose) most effectively blocked nicotine-induced CPP in mice and reversed nicotine-associated weight loss, attenuated spontaneous locomotor activity, and ameliorated multi-organ toxicity. c-Fos immunofluorescence identified the nucleus accumbens (NAc) and VTA as key responsive brain regions. Integrated analysis of network pharmacology and RNA-seq of the VTA collectively demonstrated that M511 likely acts by modulating chemical synaptic transmission and synaptic plasticity. Mechanistically, M511 inhibited PKA activation in the VTA, thereby downregulating CREB phosphorylation and subsequent GluN2B-CaMKII signaling, reducing synaptic marker proteins PSD-95 and Synapsin-Ⅰ expression, and ultimately ameliorating nicotine-induced synaptic structural and functional abnormalities. Using the PKA inhibitor H-89 mimicked the effects of M511, effectively intervening in addiction. LC-MS/MS identified 27 characteristic components, predominantly alkaloids and their derivatives, as well as flavonoids. CONCLUSION: M511 reverses nicotine addiction by normalizing the PKA-CREB-GluN2B-CaMKII signaling cascade in the VTA and ameliorating nicotine-induced synaptic plasticity abnormalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
- School of Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
- School of International Education, Nanjing University of Chinese Medicine, Nanjing 210023, China. Electronic address: aqqwang@126.com.
- School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China; State Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing Universit…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Deng, J., Zhou, Y., Mu, X., Lv, X., Jiang, H., Wang, Y., Pan, H., Huang, J., Tao, Y., Xu, G., Zhang, Y., Li, M., Wang, Q., & Lu, Z. (2026). Modified compound 511 reverses nicotine addiction by normalizing the PKA-CREB-GluN2B-CaMKII signaling pathway in the ventral tegmental area. Phytomedicine, 160, 158646. https://doi.org/10.1016/j.phymed.2026.158646
Vancouver
Deng J, Zhou Y, Mu X, Lv X, Jiang H, Wang Y, et al. Modified compound 511 reverses nicotine addiction by normalizing the PKA-CREB-GluN2B-CaMKII signaling pathway in the ventral tegmental area. Phytomedicine. 2026;160:158646. doi:10.1016/j.phymed.2026.158646
BibTeX
@article{Deng2026,
author = {Deng, Jiasi and Zhou, Yuanyuan and Mu, Xinru and Lv, Xinying and Jiang, Hongyang and Wang, Yuxuan and Pan, Haotian and Huang, Jiamin and Tao, Yinkun and Xu, Geyan and Zhang, Yi and Li, Mengran and Wang, Qian and Lu, Zhigang},
title = {Modified compound 511 reverses nicotine addiction by normalizing the PKA-CREB-GluN2B-CaMKII signaling pathway in the ventral tegmental area},
journal = {Phytomedicine},
year = {2026},
volume = {160},
pages = {158646},
doi = {10.1016/j.phymed.2026.158646}
}
EUVIMED